CEO Series: 23andMe’s Anne Wojcicki on Scient...

Harvard Business Review

Up next

How to Capture All the Advantages of Open Innovation

. 23min 57sec

Revisiting “Jobs To Be Done” with Clayton Christensen

. 25min 46sec

Recommended Episodes

301: Biotech mega-rounds, a cancer vaccine setback & CEOs keep their promise

The Readout Loud

Oruka Therapeutics CEO Lawrence Klein joins us to discuss how his company raised its first round of financing before competing with major players in the inflammation space. We also discuss the latest news in the life sciences, including the end of the Amylyx ALS saga, another use ... Show more

. 31min 37sec

372: Biotech Billionaire Anne Wojcicki, Cofounder and CEO of 23andMe

The Foundr Podcast with Nathan Chan

You’ve heard data has the power to make or break a business. Nobody knows this more than Anne Wojcicki, co-founder of biotech giant 23andMe. After 15 years of leveraging data to build a game-changing company, Wojcicki made headlines this summer when she became the latest self-mad ... Show more

. 53min 20sec

Strategy& Insider Episode 21 - Working across the silos in the healthcare ecosystem

Strategy& Insider

Sarah Lidé is the Deputy CEO of Medicon Village Innovation, which is the largest science park in Scandinavia focused on life science, based in Lund. Working at the intersection of academia, corporate players and healthcare providers, she is an expert in aligning stakeholders from ... Show more

. 50min 18sec

CRISPR's next advance is bigger than you think | Jennifer Doudna

TED Talks Daily

You've probably heard of CRISPR, the revolutionary technology that allows us to edit the DNA in living organisms. Biochemist and 2023 Audacious Project grantee Jennifer Doudna earned the Nobel Prize for her groundbreaking work in this field -- and now she's here to tell us about ... Show more

. 8min 5sec